Catalogo dei prodotti della ricerca

MERLI, Manuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.573
EU - Europa 5.543
AS - Asia 2.964
AF - Africa 663
SA - Sud America 91
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 27.842
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.154
IT - Italia 2.167
SG - Singapore 1.161
DE - Germania 839
IN - India 836
CN - Cina 782
SE - Svezia 657
FI - Finlandia 488
BJ - Benin 433
UA - Ucraina 405
RO - Romania 209
BZ - Belize 195
CA - Canada 189
GB - Regno Unito 175
BG - Bulgaria 168
ZA - Sudafrica 120
IE - Irlanda 102
RU - Federazione Russa 91
TG - Togo 85
ID - Indonesia 69
AR - Argentina 64
FR - Francia 54
BE - Belgio 46
NL - Olanda 41
MX - Messico 31
ES - Italia 23
AT - Austria 16
IR - Iran 13
TR - Turchia 13
TN - Tunisia 12
CL - Cile 11
TW - Taiwan 11
EE - Estonia 10
BR - Brasile 9
CH - Svizzera 9
KR - Corea 8
PK - Pakistan 8
AL - Albania 7
MY - Malesia 7
PL - Polonia 7
AE - Emirati Arabi Uniti 6
LK - Sri Lanka 6
LV - Lettonia 6
MM - Myanmar 6
VN - Vietnam 6
EU - Europa 5
GR - Grecia 5
SC - Seychelles 5
HK - Hong Kong 4
HR - Croazia 4
LT - Lituania 4
TH - Thailandia 4
AU - Australia 3
EG - Egitto 3
IL - Israele 3
JP - Giappone 3
KG - Kirghizistan 3
OM - Oman 3
PH - Filippine 3
PT - Portogallo 3
CO - Colombia 2
DK - Danimarca 2
EC - Ecuador 2
GT - Guatemala 2
KZ - Kazakistan 2
NG - Nigeria 2
PE - Perù 2
AZ - Azerbaigian 1
BD - Bangladesh 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
RS - Serbia 1
SI - Slovenia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 27.842
Salva come PNG Salva come JPEG
Città #
Fairfield 2.820
Ashburn 1.394
Woodbridge 1.309
Chandler 1.089
Seattle 1.052
Houston 967
Cambridge 923
Wilmington 895
Singapore 808
Ann Arbor 659
Rome 590
Princeton 572
Dearborn 523
San Jose 514
San Paolo di Civitate 464
Frankfurt am Main 446
Fasano 410
Plano 398
Beijing 370
Lawrence 276
Fremont 273
Santa Clara 267
Millbury 256
San Diego 226
Belize City 195
Dallas 188
Horia 186
Boston 177
Sofia 168
Jacksonville 165
Bremen 138
Helsinki 121
Ottawa 121
Johannesburg 115
Andover 114
Saint Louis 112
Dublin 98
Lomé 85
New York 83
Norwalk 80
Atlanta 71
San Mateo 70
Stockholm 70
Des Moines 67
Jakarta 66
Chicago 65
Los Angeles 63
Federal 62
Toronto 59
Falls Church 55
Milan 55
Boardman 54
Moscow 52
Columbus 51
Hefei 51
Brussels 43
Nanjing 38
Washington 37
Bühl 35
Mannheim 33
Falkenstein 29
London 29
Naples 28
Southend 28
Kunming 26
Phoenix 24
Jinan 23
Shanghai 22
Nanchang 21
Auburn Hills 18
Bologna 18
Guangzhou 17
Mexico City 15
Vienna 14
Indiana 12
Kairouan 12
Baotou 11
Fuzhou 11
Hebei 11
Padova 11
Redwood City 11
Acerra 10
Buffalo 10
Grafing 10
Santiago de Compostela 10
Tallinn 10
Chengdu 9
Lappeenranta 9
Shenyang 9
Zhengzhou 9
Florence 8
Istanbul 8
Turin 8
Changsha 7
Kilburn 7
Berlin 6
Genzano Di Roma 6
Leawood 6
Montréal 6
Romainville 6
Totale 21.289
Salva come PNG Salva come JPEG
Nome #
Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy 202
Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis 176
Semeiotica Medica e Metodologia Clinica, 3ª ed 176
Nutrition in cirrhosis: Dos and Don'ts 169
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 146
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 139
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 139
The multidisciplinary support in preventing alcohol relapse after liver transplantation: a single centre experience 131
Prevalence and impact of sarcopenia in non-cirrhotic portal hypertension 126
MRI reveals different Crohn's disease phenotypes in children and adults 123
Management of Hepatic Encephalopathy as an Inpatient 122
Skeletal muscle myopenia in mice model of bile duct ligation and carbon tetrachloride-induced liver cirrhosis 114
Evidence of Persistent Cognitive Impairment After Resolution of Overt Hepatic Encephalopathy 111
A low muscle mass increases mortality in compensated cirrhotic patients with sepsis 111
Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: Results of a randomized controlled trial 109
High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: A case-control study 109
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 106
Donor small-droplet macrovesicular steatosis affects liver transplant outcome in HCV-negative recipients 106
Muscle alterations are associated with minimal and overt hepatic encephalopathy in patients with liver cirrhosis 106
Failure of hepatitis B vaccination to induce either humoral or cellular immune response after liver transplantation for hepatitis B related cirrhosis 104
REGULATION OF LIVER GRAFT CHOLESTEROL SYNTHESIS AND UPTAKE AFFECTS THE OUTCOME OF HUMAN LIVER TRANSPLANTATION 104
No effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt 103
Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: Description, prevalence and risk factors 103
Donor/recipient body surface area ratio as a novel predictor of graft survival after deceased donor liver transplantation 103
Impact of Anti-Hepatitis B Core-Positive Donors in Liver Transplantation: A Survival Analysis 101
EASL Clinical Practice Guidelines on nutrition in chronic liver disease 100
Is the multidisciplinary support effective in preventing alcohol relapse after liver transplantation? 99
Intraoperative histological ischemia–reperfusion injury assessment but not clinical early allograft dysfunction predicts graft loss only in HCV positive recipients submitted to liver transplant 99
Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients 98
BACTERIAL INFECTIONS AND SEPSIS ACUTELY DETERIORATE LIVER FUNCTION IN CIRRHOTIC PATIENTS: A PROSPECTIVE STUDY 98
Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation 98
Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiology 98
Beta-blokers in patients with cirrhosis and infection: don't blame too soon. 97
Cirrhotic patients are at risk for health care-associated bacterial infections. 97
Cognitive impairment predicts the occurrence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt 97
Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt 96
CHRONIC RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION: RISK FACTORS AND A NEW PREDICTIVE SCORE 96
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial 96
Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis 96
The additive value of sarcopenia, myosteatosis and hepatic encephalopathy in the predictivity of model for end-stage liver disease 96
DONOR/RECIPIENT BODY SURFACE AREA RATIO AS A NOVEL PREDICTOR OF GRAFT SURVIVAL AFTER DECEASED DONOR LIVER TRANSPLANTATION 95
A Simplified Psychometric Evaluation for the Diagnosis of Minimal Hepatic Encephalopathy 95
Occurrence of Chronic Renal Failure in Liver Transplantation: Monitoring of Pre- and Posttransplantation Renal Function 95
Chronic renal dysfunction after liver transplantation: Incidence and risk factors 94
Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis 94
Donor liver small droplet macrovesicular steatosis is associated with reduced graft survival after liver transplantation 94
CARBON TETRACHLORIDE-INDUCED EXPERIMENTAL CIRRHOSIS IN THE RAT - A REAPPRAISAL OF THE MODEL 93
REGULATION OF LIVER GRAFT CHOLESTEROL SYNTHESIS AND UPTAKE AFFECTS THE OUTCOME OF HUMAN LIVER TRANSPLANTATION 93
Donor-to-recipient gender match in liver transplantation. A systematic review and meta-analysis 93
Does nutritional status influence the outcome in patients undergoing liver transplantation in the “MELD” era? 93
Sarcopenic obesity in fatty liver 93
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 93
A practical approach to nutritional screening and assessment in cirrhosis 92
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe 92
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide 92
Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. 91
MELDNa score is associated with psychopathology and reduced quality of life in cirrhotic patients with a liver transplant perspective 91
Proton pump inhibitors are associated with minimal and overt hepatic encephalopathy and increased mortality in patients with cirrhosis 91
Ongoing prothrombotic state in the portal circulation of cirrhotic patients 90
Long-term effect of liver transplantation on cirrhotic autonomic cardiac dysfunction 90
May sarcopenia and/or hepatic encephalopathy improve the predictivity of model for end-stage liver disease? 90
Combined Liver-Kidney Transplantation in Polycystic Disease: Case Reports 90
Sarcopenia in non-alcoholic fatty liver disease: targeting the real culprit? 89
Donor arterial oxygen pressure is a major determinant of early post-operative adverse events in adult liver transplant recipients 89
Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt 89
RIFLE Criteria and Hepatic Function in the Assessment of Acute Renal Failure in Liver Transplantation 88
Fluctuations of estimated glomerular filtration rate outside kidney disease improving global outcomes diagnostic criteria for acute kidney injury in end-stage liver disease outpatients and outcome postliver transplantation 88
Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease 87
Acute Renal Failure in Liver Transplant Recipients: Role of Pretransplantation Renal Function and 1-Year Follow-Up 87
Outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma 87
The chronic use of beta-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis. 87
ANTIVIRAL TREATMENT MAY IMPROVE THE OUTCOME OF PATIENTS WITH RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION 87
Sarco-Model: a score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 87
Conversion From Twice-Daily to Once-Daily Tacrolimus Administration in Liver Transplant Patient 86
Acute hepatitis B in a patient with OLT during treatment with peg-interferon and ribavirin for hepatitis C recurrence 86
Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice 86
Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation 85
Predictive Factors of Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Multivariate Analysis 85
A cost analysis of a broad-spectrum antibiotic therapy in the empirical treatment of health care-associated infections in cirrhotic patients 85
The impact of multidisciplinary support to alcohol misusers at risk of alcohol relapse after liver transplantation 85
Differential VEGF-A protein expression between small HCC and cirrhosis at distance from the tumor correlates with serum VEGF-A and alpha-fetoprotein 85
REGULATION OF LIVER GRAFT CHOLESTEROL SYNTHESIS AND UPTAKE AFFECTS THE OUTCOME OF HUMAN LIVER TRANSPLANTATION 85
Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis 85
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 85
Albumin infusion in cirrhotic patients with infections other than spontaneous bacterial peritonitis: End of the story? 84
Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients 84
Dietary and nutritional indications in hepatic encephalopathy 84
EFFECT OF RIBAVIRIN PRE-TREATMENT ON EARLY VIROLOGICAL RESPONSE OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION 84
Polyunsaturated fatty acids balance affects platelet NOX2 activity in patients with liver cirrhosis 84
Atorvastatin-Induced Prolonged Cholestasis with Bile Duct Damage 83
One month post-operative serum insulin predicts serum aminotransferase elevation and fibrosis progression due to HCV recurrence after liver transplantation 83
OLDER DONOR AGE IS ASSOCIATED WITH INCREASED DONOR OXIDATIVE STRESS AND FAILURE TO RESTORE BASAL PROTEIN GRAFT CONTENT AFTER ISCHEMIA REPERFUSION IN HUMAN LIVER TRANSPLANTATION 83
OXIDATIVE STRESS AND INFLAMMATION IN LIVER CIRRHOSIS: ROLE OF N-6/N-3 POLYUNSATURATED FATTY ACIDS BALANCE 83
The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey 83
CHRONIC RENAL DYSFUNCTION AFTER LIVER TRANSPLANTATION: RISK FACTORS AND A NEW PREDICTIVE SCORE 83
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (tips): PTFE-covered stent grafts versus bare stents 83
Clotting activation after transjugular intrahepatic portosystemic stent shunt 82
Changes in nutritional status after liver transplantation. 82
Donor arterial oxygen pressure is a major determinant of early post-operative adverse events in adult liver transplant recipients 82
RECIPIENT MTHFR C677T POLYMORPHISM PREDICTS PRE-TRANSPLANT CIRRHOSIS PROGRESSION AND SURVIVAL AFTER LIVER TRANSPLANTATION 82
Totale 9.866
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.531
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.531
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.311 0 0 0 0 0 2.988 976 732 707 464 280 164
2020/20212.484 251 250 82 372 61 114 45 199 208 335 112 455
2021/20224.708 64 225 439 130 593 105 100 495 727 348 578 904
2022/20234.982 941 1.046 407 953 404 371 51 193 381 51 133 51
2023/20242.489 125 291 117 179 235 505 97 168 20 324 214 214
2024/20252.050 239 346 467 301 380 317 0 0 0 0 0 0
Totale 29.107